New vaccine made of common dietary supplements could prevent COVID-19

Credit: CC0 Public Domain.

Scientists from Tel Aviv University developed a new vaccine that contains several common dietary supplements to protect against COVID-19 as well as several common winter illnesses.

The research is published in Pharmaceuticals and was conducted by Prof. Ehud Gazit et al.

Since the outbreak of the COVID-19 pandemic, humanity has led an arms race against mutations, variants, and extensive contagion, in order to minimize damage to human life and the economy.

Currently, the battle against the virus relies mainly on RNA-based vaccines, alongside several anti-viral medications.

But the COVID virus changes rapidly, and frequent updates are required to treatments and vaccines that are based on familiarizing the immune system with the virus.

The same is true for flu viruses, another widespread cause of illness and death.

In the study, the team decided to develop active vaccines made of safe and easily obtainable dietary supplements that would reduce the viral load in the body and cut down contagion.

They have known for years that food supplements containing zinc can enhance immunity to severe, viral, and chronic infections and their potentially grave consequences.

The researchers found that the consumption of zinc alone achieves a relatively low cellular content.

To enhance the effect, they combined zinc with flavonoids—polyphenolic compounds found in many fruits and vegetables.

They also added copper in order to prevent an ionic imbalance and improve the treatment’s effectiveness.

Advanced lab tests, including PCR, have shown that the new vaccines they developed did in fact reduce the viral load.

The team found a 50 to 95% decrease in the genomic replication of various groups of RNA viruses, including COVID-19, the flu virus, and others.

The team says these results are very promising, possibly enabling the development of an orally administered biological shelf treatment.

Such a product will be safe, natural, and effective against several types of viruses, including new mutations and variants—clearly an important step forward.

Sign up for our newsletter for more information about this topic.

If you care about COVID, please read studies about drugs that may reduce COVID-19 vaccine effectiveness and drugs that could help treat COVID-19.

For more information about Covid, please see recent studies about new universal antibody therapy for all COVID-19 variants, and results showing CBD from cannabis may inhibit COVID-19 infection.

Copyright © 2022 Knowridge Science Report. All rights reserved.